Popular Posts

Tuesday, 24 January 2017

Clonexa Information

FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LUNESTA® (eszopiclone) is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only).http://www.lunesta.com/PostedApprovedLabelingText.pdf 

No comments:

Post a Comment